The effects of multi mineral-vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: An RCT
- PMID: 28744522
- PMCID: PMC5510580
The effects of multi mineral-vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: An RCT
Abstract
Background: Several studies have reported the uncertain role of multi-minerals and vitamins in the prevention of preeclampsia.
Objective: The present study aims to investigate the effect of multimineral-vitamin D supplements (calcium, magnesium, zinc and Vitamin D) and vitamins (C+ E) in the prevention of preeclampsia.
Materials and methods: In this randomized clinical trial, 90 pregnant women were divided into three groups: group A received Ferrous sulfate (1 tablet/day) + one tablet of Claci-care multimineral-vitamin D containing 800mg calcium, 200mg magnesium, 8mg zinc and 400 IU Vitamin D3 per day; group B received Ferrous sulfate (1 tablet/day) + 250 mg vitamin C + 55 mg vitamin E; and the controls received only one Ferrous sulfate tablet daily.
Results: The incidence of preeclampsia in group A was significantly lower than the control group (p=0.03), while there was no significant difference between group B and controls (p=0.50), as well as groups A and B (p=0.063). The incidence of neonatal complications in the group A was significantly lower than the control group (p=0.01), while there was no significant difference between group B and control (p=0.48).
Conclusion: According to the results, calcium, magnesium, and zinc supplements have a significant effect on the prevention of preeclampsia. In addition, prescription of multimineral-vitamin D during pregnancy can be a low-cost and affordable way to reduce the incidence of preeclampsia in women who are at high risk of preeclampsia.
Keywords: Calcium; Magnesium; Preeclampsia; Prevention; Vitamin C; Vitamin D; Vitamin E; Zinc.
Conflict of interest statement
Authors have no conflict of interest.
Figures
References
-
- Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–644. - PubMed
-
- Aksoy Ü, Aksoy H, Açmaz G, Babayiğit M, Kandemir Ö. Umbilical artery serum chitotriosidase concentration in pregnancies complicated by preeclampsia and relationship between chitotriosidase levels and fetal blood flow velocity. Hypertens Pregnancy. 2013;32:401–409. - PubMed
-
- Tayyar A, Tayyar AT, Abdülrezzak Ü, Kula M, Taş M, Tayyar M. The role of midtrimester amniotic fluid leptin and endothelin-1 levels in prediction of preeclampsia. J Turk Soc Obstet Gynecol. 2012;9:37–41.
-
- Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH. Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation. Fetal Diagn Ther. 2014;36:9–17. - PubMed
LinkOut - more resources
Full Text Sources